Successful transplantation of 50 single unit pediatric kidneys ages 11 to 48 months into adult recipients

K. Jacoby, H. R. Lippman, C. E. Hura, L. McFarlin, C. F. Jones, L. H. Banowsky

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

There is currently an imbalance between the need for cadaveric kidneys for transplantation and the supply. The medical criteria for accepting cadaveric donors are changing and organs that were originally thought to be unacceptable have functioned well. Previous reports have discussed the problems with transplanting pediatric allografts less than 4 years old into adult recipients, and the results have not been encouraging. From 1986 to 1991 a total of 50 kidneys ages 11 to 48 months were transplanted as single units into adult recipients (Group A). Ninety-one adult donor cadaveric transplants were used as controls (Group B). The cadaveric transplants were 2nd or 3rd transplants in 7 of the Group A and 12 of the Group B patients. Renal preservation, storage times, and demographics were the same. Prednisone, cyclosporine, and either Minnesota ALG or OKT3 were used for immunosuppression in both groups. Imuran was added in immunologically high-risk patients. The 1-year actuarial patient and allograft survivals for Group A versus Group B were 89.5% versus 94.2% (p = 0.49) and 71.3% versus 87.8% (p = 0.01), respectively. There was no difference in allograft or patient survival in kidneys from donors 11 - 24 months of age or 25 - 48 months (p = 0.56). Renal growth, as measured by sonography, occurred while on cyclosporine A. Excretory and hormonal function as measured by creatinine and hematocrit both improved. Seventy percent of the Group A patients and 76% of the Group B patients were free from rejection in the first 2 months post transplantation (p = 0.45). This is the largest single center series using single renal units from donors less than 48 months old and demonstrates that pediatric cadaveric transplantation is both technically and physiologically feasible and that allograft and patient survival are acceptable. The subgroups within Group A of donors aged 11 - 24 and 25 - 48 months do equally well. Excretory, hormonal function, and renal growth were excellent on cyclosporine A therapy.

Original languageEnglish (US)
Pages (from-to)421-429
Number of pages9
JournalClinical Transplantation
Volume6
Issue number6
StatePublished - 1992

Fingerprint

Transplantation
Pediatrics
Kidney
Tissue Donors
Allografts
Cyclosporine
Transplants
Muromonab-CD3
Survival
Azathioprine
Growth
Prednisone
Hematocrit
Kidney Transplantation
Immunosuppression
Ultrasonography
Creatinine
Demography
Control Groups

Keywords

  • Pediatric renal transplantation

ASJC Scopus subject areas

  • Immunology
  • Transplantation

Cite this

Jacoby, K., Lippman, H. R., Hura, C. E., McFarlin, L., Jones, C. F., & Banowsky, L. H. (1992). Successful transplantation of 50 single unit pediatric kidneys ages 11 to 48 months into adult recipients. Clinical Transplantation, 6(6), 421-429.

Successful transplantation of 50 single unit pediatric kidneys ages 11 to 48 months into adult recipients. / Jacoby, K.; Lippman, H. R.; Hura, C. E.; McFarlin, L.; Jones, C. F.; Banowsky, L. H.

In: Clinical Transplantation, Vol. 6, No. 6, 1992, p. 421-429.

Research output: Contribution to journalArticle

Jacoby, K, Lippman, HR, Hura, CE, McFarlin, L, Jones, CF & Banowsky, LH 1992, 'Successful transplantation of 50 single unit pediatric kidneys ages 11 to 48 months into adult recipients', Clinical Transplantation, vol. 6, no. 6, pp. 421-429.
Jacoby K, Lippman HR, Hura CE, McFarlin L, Jones CF, Banowsky LH. Successful transplantation of 50 single unit pediatric kidneys ages 11 to 48 months into adult recipients. Clinical Transplantation. 1992;6(6):421-429.
Jacoby, K. ; Lippman, H. R. ; Hura, C. E. ; McFarlin, L. ; Jones, C. F. ; Banowsky, L. H. / Successful transplantation of 50 single unit pediatric kidneys ages 11 to 48 months into adult recipients. In: Clinical Transplantation. 1992 ; Vol. 6, No. 6. pp. 421-429.
@article{2d882f8655244866a0351d2b8d7f28fe,
title = "Successful transplantation of 50 single unit pediatric kidneys ages 11 to 48 months into adult recipients",
abstract = "There is currently an imbalance between the need for cadaveric kidneys for transplantation and the supply. The medical criteria for accepting cadaveric donors are changing and organs that were originally thought to be unacceptable have functioned well. Previous reports have discussed the problems with transplanting pediatric allografts less than 4 years old into adult recipients, and the results have not been encouraging. From 1986 to 1991 a total of 50 kidneys ages 11 to 48 months were transplanted as single units into adult recipients (Group A). Ninety-one adult donor cadaveric transplants were used as controls (Group B). The cadaveric transplants were 2nd or 3rd transplants in 7 of the Group A and 12 of the Group B patients. Renal preservation, storage times, and demographics were the same. Prednisone, cyclosporine, and either Minnesota ALG or OKT3 were used for immunosuppression in both groups. Imuran was added in immunologically high-risk patients. The 1-year actuarial patient and allograft survivals for Group A versus Group B were 89.5{\%} versus 94.2{\%} (p = 0.49) and 71.3{\%} versus 87.8{\%} (p = 0.01), respectively. There was no difference in allograft or patient survival in kidneys from donors 11 - 24 months of age or 25 - 48 months (p = 0.56). Renal growth, as measured by sonography, occurred while on cyclosporine A. Excretory and hormonal function as measured by creatinine and hematocrit both improved. Seventy percent of the Group A patients and 76{\%} of the Group B patients were free from rejection in the first 2 months post transplantation (p = 0.45). This is the largest single center series using single renal units from donors less than 48 months old and demonstrates that pediatric cadaveric transplantation is both technically and physiologically feasible and that allograft and patient survival are acceptable. The subgroups within Group A of donors aged 11 - 24 and 25 - 48 months do equally well. Excretory, hormonal function, and renal growth were excellent on cyclosporine A therapy.",
keywords = "Pediatric renal transplantation",
author = "K. Jacoby and Lippman, {H. R.} and Hura, {C. E.} and L. McFarlin and Jones, {C. F.} and Banowsky, {L. H.}",
year = "1992",
language = "English (US)",
volume = "6",
pages = "421--429",
journal = "Clinical Transplantation",
issn = "0902-0063",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Successful transplantation of 50 single unit pediatric kidneys ages 11 to 48 months into adult recipients

AU - Jacoby, K.

AU - Lippman, H. R.

AU - Hura, C. E.

AU - McFarlin, L.

AU - Jones, C. F.

AU - Banowsky, L. H.

PY - 1992

Y1 - 1992

N2 - There is currently an imbalance between the need for cadaveric kidneys for transplantation and the supply. The medical criteria for accepting cadaveric donors are changing and organs that were originally thought to be unacceptable have functioned well. Previous reports have discussed the problems with transplanting pediatric allografts less than 4 years old into adult recipients, and the results have not been encouraging. From 1986 to 1991 a total of 50 kidneys ages 11 to 48 months were transplanted as single units into adult recipients (Group A). Ninety-one adult donor cadaveric transplants were used as controls (Group B). The cadaveric transplants were 2nd or 3rd transplants in 7 of the Group A and 12 of the Group B patients. Renal preservation, storage times, and demographics were the same. Prednisone, cyclosporine, and either Minnesota ALG or OKT3 were used for immunosuppression in both groups. Imuran was added in immunologically high-risk patients. The 1-year actuarial patient and allograft survivals for Group A versus Group B were 89.5% versus 94.2% (p = 0.49) and 71.3% versus 87.8% (p = 0.01), respectively. There was no difference in allograft or patient survival in kidneys from donors 11 - 24 months of age or 25 - 48 months (p = 0.56). Renal growth, as measured by sonography, occurred while on cyclosporine A. Excretory and hormonal function as measured by creatinine and hematocrit both improved. Seventy percent of the Group A patients and 76% of the Group B patients were free from rejection in the first 2 months post transplantation (p = 0.45). This is the largest single center series using single renal units from donors less than 48 months old and demonstrates that pediatric cadaveric transplantation is both technically and physiologically feasible and that allograft and patient survival are acceptable. The subgroups within Group A of donors aged 11 - 24 and 25 - 48 months do equally well. Excretory, hormonal function, and renal growth were excellent on cyclosporine A therapy.

AB - There is currently an imbalance between the need for cadaveric kidneys for transplantation and the supply. The medical criteria for accepting cadaveric donors are changing and organs that were originally thought to be unacceptable have functioned well. Previous reports have discussed the problems with transplanting pediatric allografts less than 4 years old into adult recipients, and the results have not been encouraging. From 1986 to 1991 a total of 50 kidneys ages 11 to 48 months were transplanted as single units into adult recipients (Group A). Ninety-one adult donor cadaveric transplants were used as controls (Group B). The cadaveric transplants were 2nd or 3rd transplants in 7 of the Group A and 12 of the Group B patients. Renal preservation, storage times, and demographics were the same. Prednisone, cyclosporine, and either Minnesota ALG or OKT3 were used for immunosuppression in both groups. Imuran was added in immunologically high-risk patients. The 1-year actuarial patient and allograft survivals for Group A versus Group B were 89.5% versus 94.2% (p = 0.49) and 71.3% versus 87.8% (p = 0.01), respectively. There was no difference in allograft or patient survival in kidneys from donors 11 - 24 months of age or 25 - 48 months (p = 0.56). Renal growth, as measured by sonography, occurred while on cyclosporine A. Excretory and hormonal function as measured by creatinine and hematocrit both improved. Seventy percent of the Group A patients and 76% of the Group B patients were free from rejection in the first 2 months post transplantation (p = 0.45). This is the largest single center series using single renal units from donors less than 48 months old and demonstrates that pediatric cadaveric transplantation is both technically and physiologically feasible and that allograft and patient survival are acceptable. The subgroups within Group A of donors aged 11 - 24 and 25 - 48 months do equally well. Excretory, hormonal function, and renal growth were excellent on cyclosporine A therapy.

KW - Pediatric renal transplantation

UR - http://www.scopus.com/inward/record.url?scp=0027024197&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027024197&partnerID=8YFLogxK

M3 - Article

C2 - 10148020

AN - SCOPUS:0027024197

VL - 6

SP - 421

EP - 429

JO - Clinical Transplantation

JF - Clinical Transplantation

SN - 0902-0063

IS - 6

ER -